Now available in more than 3,000 orthodontic locations in North America, AcceleDent is being integrated into orthodontic practices in the United States and internationally as standard of care for accelerated orthodontic treatment. AcceleDent is an FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent and relieves pain often associated with treatment.
Patients simply bite down on AcceleDent’s gently pulsating mouthpiece for 20 minutes daily, and the hands-free, noninvasive device employs patented SoftPulse Technology that accelerates bone remodeling and tooth movement at the cellular level.
Many respected orthodontists, including Dr. Sam Daher, Dr. Sonia Palleck, Dr. Jay Bowman and Dr. John Graham, choose AcceleDent as the preferred accelerated treatment modality because it has been clinically proven to address the two most common barriers to treatment: length of treatment and discomfort.
Manufactured by OrthoAccel Technologies, AcceleDent’s rapid adoption by orthodontists is credited to both a growing body of clinical evidence supporting the device’s safety and effectiveness, as well as high patient satisfaction among AcceleDent users.
In September 2015, a peer-reviewed article published in Angle Orthodontist titled “Pain Control in Orthodontics Using a Micropulse Vibration Device: A Randomized Clinical Trial” reported that micropulse vibration, as used in AcceleDent, significantly lowers biting pain and overall pain during orthodontic treatment.
Orthodontists such as Dr. Katie Graber, who practices in Illinois, say the reduction in discomfort is a huge benefit of treating patients with AcceleDent.
“This study clearly demonstrates that, in addition to faster tooth movement, AcceleDent provides ‘pure’ pain management for orthodontic patients who frequently report discomfort during treatment,” Graber said. “I’ve found that patients and parents appreciate AcceleDent’s reduction in discomfort because it eliminates the need for over-the-counter or prescription pain medication.”
Another clinical trial appeared in the September 2015 issue of Seminars in Orthodontics, and the results revealed that pulsatile forces, which AcceleDent employs, significantly accelerate tooth movement. This prospective, double-blind, randomized, controlled trial, demonstrates that gentle, non-invasive vibration increases the rate of tooth movement.
This scientific evidence reinforces the clinical results that AcceleDent providers have been achieving with this medical device for the past several years. The evidence is underscored by consistently positive patient reviews. In an independent survey, 100 percent of patients surveyed report they are satisfied with their experience using AcceleDent.
“The strong support from orthodontists and consumers is how we know that AcceleDent is such a game changer for the orthodontic industry,” said Michael K. Lowe, president and CEO of OrthoAccel. “Orthodontists understand the science that makes AcceleDent work, and patients are eager to receive the benefits of accelerated orthodontic treatment with AcceleDent.”
OrthoAccel captured No. 69 on the 2015 Deloitte Fast 500 ranking of the fastest growing technology companies in North America. Among the top 100 companies ranked on the prestigious list are some of this era’s most dynamic and respected technology brands such as Tesla, Fitbit and Twitter.
“The fact that OrthoAccel is the only orthodontic company ranked on the 2015 Deloitte Fast 500 shows the wealth of industry experience that our team has,” Lowe said. “As an innovation company, we remain laser-focused on revolutionizing the orthodontic industry by enhancing the patient treatment experience.”
(Source: OrthoAccel Technologies)
Patient-centric care has been pervasive across health systems in the United States during the last several years (Epstein, Lesser and Levinson, 2010). The ...
More than six decades ago my incredible journey toward the pursuit of excellence in the dental profession began. Over the years I lived in five different ...
Zimmer Biomet has released a clinical compendium demonstrating evidence of the BioBoost Effect, a novel reproducible biological effect following placement ...
Dentium recently announced the results of its long-term clinical case study. The study, conducted for more than 10 years, has successfully shown Dentium ...
SOUTH BEND, Ind., USA: As reported by the dental manufacturer Heraeus USA, its composite Venus Diamond and Tetric EvoCeram (Ivoclar Vivadent) have achieved ...
NEW YORK, N.Y., USA: The Academy of Osseointegration is recognized as the premier association for professionals interested in implant dentistry. It has ...
ROSEMONT, Ill., USA: The American Academy of Orthopedic Surgeons (AAOS), and the American Dental Association (ADA) found that there is insufficient evidence...
CHICAGO, Ill., USA: Despite provocative reporting and sensational headlines, the American Association of Endodontists says there is no evidence that ...
The American Academy of Periodontology (AAP), a leading professional organization dedicated to the dental specialty of periodontics, has published its ...
NEW YORK, US: Patients depend on dental professionals to provide optimal care, whether for routine prophylaxis or complex procedures. Delivering ...
Live webinar
Thu. 11 September 2025
1:00 PM EST (New York)
Live webinar
Mon. 15 September 2025
1:00 PM EST (New York)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
11:00 AM EST (New York)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
12:30 PM EST (New York)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
1:00 PM EST (New York)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Tue. 16 September 2025
8:00 PM EST (New York)
To post a reply please login or register